Hormigo et al. observed that levels of MMP-9 were higher in the serum samples of patients with high-grade glioma after surgery, while the MMP-9 concentrations were significantly lower in glioblastoma patients with no radiographic evidence of disease in comparison to the subjects with active tumour [45]. The gene discussed is MMP9; the disease is glioma.